(Q40793204)

23 September 2017

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout (English)

1 reference

23 September 2017

3

Arthur Kavanaugh

1 reference

23 September 2017

Peter E Lipsky

1

1 reference

23 September 2017

Leonard H Calabrese

2

1 reference

23 September 2017

John S Sundy

4

1 reference

23 September 2017

David Wright

5

1 reference

23 September 2017

Marsha Wolfson

6

1 reference

23 September 2017

Michael A Becker

7

1 reference

23 September 2017

4 March 2014

1 reference

Arthritis Research and Therapy

23 September 2017

1 reference

23 September 2017

16

1 reference

23 September 2017

2

1 reference

23 September 2017

R60

1 reference

https://scigraph.springernature.com/pub.10.1186/ar4497

23 September 2017

0 references

cites work

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Delivery of therapeutic proteins

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Clinical manifestations of hyperuricemia and gout.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

The impact of PEGylation on biological therapies

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

PEG-uricase in the management of treatment-resistant gout and hyperuricemia

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

Purification and properties of solubilized uricase.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060440

A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers

19 August 2018

1 reference

12 December 2020

Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout

1 reference

12 December 2020

Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes

1 reference

12 December 2020

Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR4497

1 reference

23 September 2017

1 reference

23 September 2017

1 reference